financetom
HAIN
financetom
/
Consumer Staples
/
HAIN
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
The Hain Celestial Group, Inc.HAIN
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

The Hain Celestial Group, Inc. manufactures, markets, and sells organic and natural products in United States, United Kingdom, Europe, and internationally.

It operates through two segments: North America and International. The company offers infant formula; infant, toddler, and kids' food; plant-based beverages and frozen desserts, such as soy, rice, oat, and spelt; and condiments.

It also provides cooking and culinary oils; cereal bars; fresh and aseptic soups; yogurts; and nut butters.

In addition, the company offers hot-eating desserts, refrigerated and frozen plant-based meat-alternative products, jams, fruit spreads, jellies, honey, natural sweeteners, syrups, dessert sauces, and marmalade products, as well as other food products.

Further, it provides snack products comprising potato, root vegetable and other exotic vegetable chips, straws, tortilla chips; and personal care products that include hand, skin, hair, and oral care products, as well as deodorants, baby food, sunscreens, and other products under the Alba Botanica, Avalon Organics, Earth's Best, JASON, Live Clean, and Queen Helene brands name.

Additionally, the company offers herbal, green, black, wellness, rooibos, and chai tea under the Celestial Seasonings brand.

It sells pantry products under the Spectrum, Spectrum Essentials, MaraNatha, Imagine broths, Hain Pure Foods, Health Valley, and Hollywood brands.

It sells its products through specialty and natural food distributors, supermarkets, natural food stores, mass-market and e-commerce retailers, food service channels and clubs, and drug and convenience stores.

The company was incorporated in 1993 and is headquartered in Hoboken, New Jersey.

Latest News >
Alzamend Neuro Halts Equity Offering Program, Prioritizing Shareholder Value Amid Strategic Shift, Shares Slide
Alzamend Neuro Halts Equity Offering Program, Prioritizing Shareholder Value Amid Strategic Shift, Shares Slide
May 7, 2024
Alzamend Neuro, Inc. ( ALZN ) made waves Tuesday when the company announced its decision to terminate its “at-the-market” equity offering program. Shares were down nearly 12% at last check. What To Know: The move, aimed at minimizing uncertainty and preserving shareholder value, saw Alzamend cease further sales of common stock under its at-the-market equity offering, effectively concluding its obligations...
US electric utility Sempra's profit falls 17% in first quarter
US electric utility Sempra's profit falls 17% in first quarter
May 7, 2024
May 7 (Reuters) - Sempra Energy posted a 17% drop in first-quarter profit on Tuesday as it logged sharply lower revenue from its natural gas operations, although increases in its Texas power business helped cushion the fall. Sempra ( SRE ), which supplies electricity and natural gas to nearly 40 million customers in parts of California, Texas and Mexico, said...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Tempur Sealy International, Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Tempur Sealy International, Inc.
May 7, 2024
02:35 PM EDT, 05/07/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target $6 to $56, 19.4x our 2024 EPS of $2.88 (cut from $2.92; 2025 up to $3.23 from $2.99) vs. the 17x long-term average forward P/E....
Research Alert: CFRA Keeps Hold Opinion On Shares Of Realty Income Corporation
Research Alert: CFRA Keeps Hold Opinion On Shares Of Realty Income Corporation
May 7, 2024
02:40 PM EDT, 05/07/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our target price at $56 on a forward P/FFO of 13.3x our 2024 FFO estimate, a discount to O's 10-year average multiple (18.0x) as higher interest rates put...
Copyright 2023-2025 - www.financetom.com All Rights Reserved